证券之星消息，7月31日医药商业板块较上一交易日下跌1.61%，人民同泰领跌。当日上证指数报收于 3573.21，下跌1.18%。深证成指报收于11009.77，下跌1.73%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 301126 | 达嘉维康 | 12.52 | 3.81% | | 33.74万 | 4.37 乙 | | 301015 | 百洋医药 | 22.07 | 0.68% | | 12.32万 | 2.71亿 | | 603108 | 润达医疗 | 18.31 | 0.60% | | 34.20万 | 6.33亿 | | 002589 | 瑞康医药 | 3.13 | 0.00% | | 37.63万 | 1.18亿 | | 300937 | 药易购 | 30.41 | -0.13% | | 5.74万 | 1.77亿 | | 301017 | 激干平民 | 13.08 | -0.38% | | 7.56万 | 9956.06万 | ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603716 | 塞力医疗 | 31.62 | -4.62% | 53.88万 | 17.35 Z | | 002727 | 一心室 | 15.16 | -1.62% | 24.81万 | 3.74亿 | | 301408 | 华人健康 | 14.23 | -1.52% | 12.38万 | 1.76亿 | | 301126 | 达嘉维康 | 11.81 | -1.34% | 12.83万 | 1.54亿 | | 600713 | 南京医药 | 5.30 | -0.38% | 10.15万 | 5359.40万 | | 603939 | 益丰药房 | 23.85 | -0.29% | 13.61万 | 3.24亿 | | 600511 | 国药股份 | 29.85 | -0.23% | 3.59万 | 1.07亿 | | 605266 | 健之佳 | 21.93 | -0.09% | 2.33万 | 5098.20万 | | 002589 | 瑞康 ...

New Stock Issuance - New stock issued by Dingjia Precision at a price of 11.16 on July 22, 2025[1] - ST Kelly's tender offer period is from July 17 to August 15, 2025[1] - ST Zitian and other companies have also announced new stock issuances[1] Market Alerts - Significant abnormal fluctuations reported for several stocks including Guangshengtang and Huayin Power[1] - Multiple companies have disclosed announcements regarding stock performance and market activities[1] - The report includes links to detailed announcements for various stocks, indicating ongoing market monitoring[1]

Market Overview - As of July 21, the Shanghai Composite Index closed at 3559.79 points, with a change of +0.72% [1] - The Shenzhen Component Index closed at 11007.49 points, with a change of +0.86% [1] - The ChiNext Index closed at 2296.88 points, with a change of +0.87% [1] Trading Volume Analysis - A total of 2843 stocks saw an increase in average transaction volume, with 159 stocks experiencing an increase of over 50% [1] - 1706 stocks reported a decrease in average transaction volume [1] - Notable stocks with significant increases in transaction volume include Zhuhai Design (+545.48%), Huaxin Cement (+346.40%), and Western Construction (+343.83%) [1] Active Stocks by Transaction Count - The top three stocks with the highest increase in transaction count were Han Commercial Group (+4471.98%), Renmin Tongtai (+1372.79%), and Xuch Electric (+800.94%) [2] - Other notable stocks with significant increases in transaction count include Yongfu Co. (+737.52%) and Liding Optoelectronics (+722.29%) [2] Stocks with Significant Increases in Both Transaction Volume and Count - Construction Machinery showed a daily increase of +9.88%, with transaction volume up by 236.12% and transaction count up by 86.06% [3] - Other stocks with both metrics exceeding 50% include Shoufang Cement, Tianshan Shares, and Guotong Shares, all showing substantial increases in both transaction volume and count [4]

New Stock Issuance - The new stock issued by Hanguo Group is priced at 15.43 RMB per share[1] - The subscription period for the tender offer of ST Kelly is from July 17, 2025, to August 15, 2025[1] Abnormal Fluctuations - Several stocks, including ST Zitian and Guangshengtang, have reported severe abnormal fluctuations[2] - The announcement links for stocks experiencing abnormal fluctuations are provided for investor reference[2] Market Updates - A total of 30 stocks have been listed for trading updates, with various announcements made between July 15 and July 21, 2025[1] - The report includes links to detailed announcements for each stock, ensuring transparency and accessibility for investors[1]

医药商业板块震荡走高，人民同泰（600829）拉升涨停，华人健康（301408）、塞力医疗（603716）、 漱玉平民（301017）、药易购（300937）跟涨。 ...

（文章来源：证券时报网） 人民同泰盘中涨停，已连收3个涨停板，截至9:27，该股报10.16元，换手率0.70%，成交量405.25万股， 成交金额4117.34万元，涨停板封单金额为3.07亿元。连续涨停期间，该股累计上涨32.98%，累计换手 率为5.05%。最新A股总市值达58.92亿元。 近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.07.18 | 10.00 | 1.44 | 3326.95 | | 2025.07.17 | 9.95 | 2.91 | 7339.12 | | 2025.07.16 | 2.14 | 1.59 | 434.32 | | 2025.07.15 | -1.84 | 1.43 | -51.59 | | 2025.07.14 | 0.79 | 1.18 | 2.88 | | 2025.07.11 | -0.13 | 1.22 | -354.31 | | 2025.07.10 | 1.34 | 1.51 | 241.99 | | 2025.07.09 | -0.1 ...

Market Performance - A-shares steadily advanced this week, with the ChiNext Index reaching a new high for the year and the Shenzhen Component Index hitting a four-month high, approaching its highest point of the year [1] - Weekly trading volume increased to 7.73 trillion yuan, marking the largest weekly trading volume in three months [1] Fund Inflows - Leverage funds actively entered the market, with most industries under the Shenwan first-level industry classification seeing net buying, particularly the computer industry with over 4.4 billion yuan and the electronics industry with over 3 billion yuan [2] - The electronic, biopharmaceutical, and automotive sectors each received over 20 billion yuan in net inflows, while the non-bank financial sector saw a net outflow of over 8.3 billion yuan [2] Rare Earth Demand - The rare earth sector performed strongly, with the rare earth permanent magnet index reaching a three-and-a-half-year high [3] - Demand for rare earths is expected to grow rapidly due to advancements in humanoid robots and electric vehicles, with estimates suggesting a demand of at least 70,000 tons of neodymium-iron-boron by 2025 [3] Energy Metals - The energy metals sector, including lithium and cobalt, reached a two-year high, with lithium carbonate futures breaking 70,000 yuan/ton, marking a 20% increase from recent lows [4] - Short-term lithium salt supply may decline due to reduced exports from Chile and domestic production halts, leading to a potential price stabilization [4] Biopharmaceutical Sector - The biopharmaceutical sector saw significant gains, with the innovative drug index hitting record highs multiple times this week [6] - Notable stocks in the sector, such as Lianhuan Pharmaceutical and Aosaikang, experienced consecutive trading halts, with some stocks showing year-to-date gains exceeding 200% [6][7] Earnings Forecasts - Several pharmaceutical companies have recently forecasted substantial profit increases for the first half of 2025, with estimates suggesting net profit growth exceeding 19 times for some firms [7]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 哈药集团人民同泰医药股份有限公司 股票交易异常波动公告 ●哈药集团人民同泰医药股份有限公司（以下简称"公司"）股票于 2025 年 7 月 16 日、 2025 年 7 月 17 日、2025 年 7 月 18 日连续 3 个交易日内日收盘价格涨幅偏离值累计超过 20%， 属于《上海证券交易所交易规则》规定的股票交易异常波动情形。 ●经公司自查，并向公司控股股东哈药集团股份有限公司、间接控股股东哈药集团有限 公司询证，不存在应披露而未披露的重大事项或重要信息。 ●敬请广大投资者注意二级市场交易风险，理性投资。 一、股票交易异常波动的具体情况 证券代码：600829 证券简称：人民同泰 编号：临 2025-021 （三）公司未发现对公司股票交易价格产生重大影响的重大事件，未发现需 要澄清或回应的媒体报道或市场传闻。 （四）经公司核实，未发现公司控股股东、间接控股股东及公司董事、高级 管理人员在公司本次股票交易异常波动期间买卖公司股票的情况。 三、相关风险提示 公司股 ...

Core Viewpoint - The stock of Renmin Tongtai has experienced a significant price increase, with a cumulative rise of over 20% in the closing prices over three consecutive trading days, indicating unusual trading volatility [1] Company Summary - Renmin Tongtai announced that its stock price increased on July 16, 17, and 18, 2025, with the cumulative closing price increase exceeding 20% [1] - The company conducted a self-examination and confirmed with its controlling shareholder, Harbin Pharmaceutical Group Co., Ltd., that there are no undisclosed significant events or important information [1] - The main business activities of the company include pharmaceutical wholesale, retail, logistics services, and medical services, which have not undergone significant changes [1]